![Jethro Holter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jethro Holter
Presidente en GENETIC ANALYSIS .
Fortuna: 196 394 $ al 31/05/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Ronny Hermansen | M | 62 | 10 años | |
Eilert Aamodt | M | 54 | 3 años | |
Rune Sørum | M | 68 | 14 años | |
Rolf Einar Engstad | M | 65 |
Biotec BetaGlucans AS
![]() Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | - |
Christina Casèn | F | 64 | 15 años | |
Olav Lanes | M | 52 |
ArcticZymes AS
![]() ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | 14 años |
Gerd Nilsen | M | 56 |
ArcticZymes AS
![]() ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | 14 años |
Børge Sørvoll | M | 49 |
Biotec BetaGlucans AS
![]() Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | - |
Camilla Huse Bondesson | M | 66 | 4 años | |
Marit Sjo Lorentzen | M | 56 |
Biotec BetaGlucans AS
![]() Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | - |
Kari Furu | M | 44 | 8 años | |
Lars Tiller | M | - | 2 años | |
Dirk Hahneiser | M | 56 | 2 años | |
Darren Ellis | M | - | 2 años | |
Michael Akoh | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Svein Wilhelm Faye Lien | M | 70 | 7 años | |
Martin Hunt | M | 66 | - | |
Volker Wedershoven | M | - | - | |
Kjersti Grimsrud | F | 63 | 4 años | |
Richard Stuart Godfrey | M | 58 | - | |
Arne Reinemo | M | - | - | |
Inger Rydin | F | 67 | 5 años | |
Christian Jørgensen | M | 65 | 2 años | |
Per Matsson | M | 70 | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Noruega | 24 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jethro Holter
- Red Personal